Article
Mutations in MYO9B are associated with Charcot-Marie-Tooth disease type 2 neuropathies and isolated optic atrophy.
European journal of neurology - 1 Feb 2023
Cipriani Silvia, Guerrero-Valero Marta, Tozza Stefano, Zhao Edward, Vollmer Veith, Beijer Danique, Danzi Matt, Rivellini Cristina, Lazarevic Dejan, Pipitone Giovanni Battista, Grosz Bianca Rose, Lamperti Costanza, Marzoli Stefania Bianchi, Carrera Paola, Devoto Marcella, Pisciotta Chiara, Pareyson Davide, Kennerson Marina, Previtali Stefano C, Zuchner Stephan, Scherer Steven S, Manganelli Fiore, Bähler Martin, Bolino Alessandra
Abstract excerpt
BACKGROUND AND PURPOSE: Charcot-Marie-Tooth disease (CMT) is a heterogeneous group of disorders caused by mutations in at least 100 genes. However, approximately 60% of cases with axonal neuropathies (CMT2) still remain without a genetic diagnosis. We aimed at identifying novel disease genes responsible for CMT2. METHODS: We performed whole exome sequencing and targeted next generation sequencing panel analyses...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
